Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Vibrionaceae

ABSTRACT: Vibrionaceae Genome sequencing and assembly

PROVIDER: PRJNA494150 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR7958972_1.fastq.gz	Fastqsanger.gz
	SRR7958972_2.fastq.gz	Fastqsanger.gz
	SRR7959178_1.fastq.gz	Fastqsanger.gz
	SRR7959178_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Vibrionaceae

Project description:Vibrionaceae Genome sequencing

| PRJNA164627 | ENA

Vibrionaceae

Project description:Vibrionaceae overview

| PRJNA187008 | ENA

Vibrionaceae

Project description:New taxa description on Vibrionaceae

| PRJDB5109 | ENA

Vibrionaceae

Project description:Evolution of alginate metabolism in Vibrionaceae

| PRJNA318805 | ENA

Vibrionaceae

Project description:Genomic characterization of a polymicrobial infection associated with a disease outbreak in Pacific white shrimp (Litopenaeus vannamei) Genome sequencing and assembly

| PRJNA446072 | ENA

Vibrio

Project description:Vibrionaceae genome

| PRJDB11924 | ENA

Identification of promoter activity in gene-less cassettes from Vibrionaceae superintegrons

Project description:Identification of promoter activity in gene-less cassettes from Vibrionaceae superintegrons

| PRJNA955808 | ENA

Vibrionaceae bacterium strain:SE-01

Project description:Parasalinivibrio latis TLL-SE01/BCRC 81435/JCM 36283 Genome sequencing and assembly

| PRJNA848858 | ENA

Vibrio

Project description:Vibrionaceae systematics

| PRJDB4572 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data